US Patent 8466259 Adjuvants
Patent 8466259 was granted and assigned to National Health Research Institutes on June, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 27 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 30 Nov, 2023
Golden AI
Edits made to:
Article (+101 characters)
Article
Patent abstract
Disclosed are lipopeptides or lipoproteins, related compositions, and related methods.
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08466259 Adjuvants US Patent 8466259 Adjuvants
Infobox
Patent Number
0846625900
Patent Number
846625900
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084662590
Date of Patent
June 18, 2013
0Patent Application Number
127025670
Date Filed
February 9, 2010
0Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
084662590
Date of Patent
June 18, 2013
0Patent Application Number
127025670
Date Filed
February 9, 2010
0Patent Primary Examiner
Edits on 17 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08466259 Adjuvants
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08466259
Date of patent
June 18, 2013
Patent application number
12702567
Date Filed
February 9, 2010
Patent primary examiner
Find more entities like US Patent 8466259 Adjuvants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
